These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
656 related articles for article (PubMed ID: 19452554)
1. Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study. Rodriguez-Oroz MC; Lage PM; Sanchez-Mut J; Lamet I; Pagonabarraga J; Toledo JB; García-Garcia D; Clavero P; Samaranch L; Irurzun C; Matsubara JM; Irigoien J; Bescos E; Kulisevsky J; Pérez-Tur J; Obeso JA Mov Disord; 2009 Jul; 24(10):1437-44. PubMed ID: 19452554 [TBL] [Abstract][Full Text] [Related]
2. Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease. Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Jarosz M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Sławek J Pharmacogenet Genomics; 2012 Oct; 22(10):716-24. PubMed ID: 22890010 [TBL] [Abstract][Full Text] [Related]
3. Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients. Camicioli RM; Bouchard TP; Somerville MJ Mov Disord; 2009 Jan; 24(2):176-82. PubMed ID: 18951534 [TBL] [Abstract][Full Text] [Related]
6. Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease. Irizarry MC; Gurol ME; Raju S; Diaz-Arrastia R; Locascio JJ; Tennis M; Hyman BT; Growdon JH; Greenberg SM; Bottiglieri T Neurology; 2005 Nov; 65(9):1402-8. PubMed ID: 16275827 [TBL] [Abstract][Full Text] [Related]
7. Plasma homocysteine levels and Parkinson disease: disease progression, carotid intima-media thickness and neuropsychiatric complications. Hassin-Baer S; Cohen O; Vakil E; Sela BA; Nitsan Z; Schwartz R; Chapman J; Tanne D Clin Neuropharmacol; 2006; 29(6):305-11. PubMed ID: 17095893 [TBL] [Abstract][Full Text] [Related]
8. [Homocysteine and cognitive impairment in Parkinson's disease]. Martín-Fernández JJ; Carles-Díes R; Cañizares F; Parra S; Avilés F; Villegas I; Morsi-Hassan O; Fernández-Barreiro A; Herrero MT Rev Neurol; 2010 Feb 1-15; 50(3):145-51. PubMed ID: 20146187 [TBL] [Abstract][Full Text] [Related]
9. Methylenetetrahydrofolate reductase polymorphisms and plasma homocysteine in levodopa-treated and non-treated Parkinson's disease patients. Yuan RY; Sheu JJ; Yu JM; Hu CJ; Tseng IJ; Ho CS; Yeh CY; Hung YL; Chiang TR J Neurol Sci; 2009 Dec; 287(1-2):64-8. PubMed ID: 19786283 [TBL] [Abstract][Full Text] [Related]
10. Contribution of the MTHFR gene to the causal pathway for depression, anxiety and cognitive impairment in later life. Almeida OP; Flicker L; Lautenschlager NT; Leedman P; Vasikaran S; van Bockxmeer FM Neurobiol Aging; 2005 Feb; 26(2):251-7. PubMed ID: 15582752 [TBL] [Abstract][Full Text] [Related]
11. [Correlation analysis between plasma homocysteine level and polymorphism of homocysteine metabolism related enzymes in ischemic cerebrovascular or cardiovascular diseases]. Zhang G; Dai C Zhonghua Xue Ye Xue Za Zhi; 2002 Mar; 23(3):126-9. PubMed ID: 12015064 [TBL] [Abstract][Full Text] [Related]
12. Relationship of cognitive function with B vitamin status, homocysteine, and tissue factor pathway inhibitor in cognitively impaired elderly: a cross-sectional survey. Kim G; Kim H; Kim KN; Son JI; Kim SY; Tamura T; Chang N J Alzheimers Dis; 2013; 33(3):853-62. PubMed ID: 23042212 [TBL] [Abstract][Full Text] [Related]
13. Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging. Kado DM; Karlamangla AS; Huang MH; Troen A; Rowe JW; Selhub J; Seeman TE Am J Med; 2005 Feb; 118(2):161-7. PubMed ID: 15694902 [TBL] [Abstract][Full Text] [Related]
14. Relations between homocysteine, folate and vitamin B12 in vascular dementia and in Alzheimer disease. Köseoglu E; Karaman Y Clin Biochem; 2007 Aug; 40(12):859-63. PubMed ID: 17532313 [TBL] [Abstract][Full Text] [Related]
15. Association of cognitive impairment with plasma levels of folate, vitamin B12 and homocysteine in the elderly. Dimopoulos N; Piperi C; Salonicioti A; Psarra V; Gazi F; Nounopoulos C; Lea RW; Kalofoutis A In Vivo; 2006; 20(6B):895-9. PubMed ID: 17203786 [TBL] [Abstract][Full Text] [Related]
16. Mild hyperhomocysteinemia and low folate concentrations as risk factors for cervical arterial dissection. Arauz A; Hoyos L; Cantú C; Jara A; Martínez L; García I; Fernández Mde L; Alonso E Cerebrovasc Dis; 2007; 24(2-3):210-4. PubMed ID: 17596690 [TBL] [Abstract][Full Text] [Related]
17. Homocysteine concentrations and molecular analysis in patients with congenital heart defects. Galdieri LC; Arrieta SR; Silva CM; Pedra CA; D'Almeida V Arch Med Res; 2007 Feb; 38(2):212-8. PubMed ID: 17227731 [TBL] [Abstract][Full Text] [Related]
18. Plasma homocysteine concentrations and the single nucleotide polymorphisms in the methionine synthase gene (MTR 2756A>G): Associations with the polycystic ovary syndrome An observational study. Palep-Singh M; Picton HM; Yates ZR; Barth JH; Balen AH Eur J Obstet Gynecol Reprod Biol; 2008 Jun; 138(2):180-6. PubMed ID: 18281142 [TBL] [Abstract][Full Text] [Related]
19. The influence of genetic and environmental factors on plasma homocysteine concentrations in a population at high risk for coronary artery disease. Bowron A; Scott J; Stansbie D Ann Clin Biochem; 2005 Nov; 42(Pt 6):459-62. PubMed ID: 16259797 [TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of genes involved in homocysteine metabolism in preeclampsia and in uncomplicated pregnancies. Also-Rallo E; Lopez-Quesada E; Urreizti R; Vilaseca MA; Lailla JM; Balcells S; Grinberg D Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):45-52. PubMed ID: 15866085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]